416 related articles for article (PubMed ID: 26082511)
1. Hepatitis B Virus Reactivation During Successful Treatment of Hepatitis C Virus With Sofosbuvir and Simeprevir.
Collins JM; Raphael KL; Terry C; Cartwright EJ; Pillai A; Anania FA; Farley MM
Clin Infect Dis; 2015 Oct; 61(8):1304-6. PubMed ID: 26082511
[TBL] [Abstract][Full Text] [Related]
2. Editorial Commentary: Another Call to Cure Hepatitis B.
Balagopal A; Thio CL
Clin Infect Dis; 2015 Oct; 61(8):1307-9. PubMed ID: 26082512
[No Abstract] [Full Text] [Related]
3. Fulminant hepatitis B reactivation leading to liver transplantation in a patient with chronic hepatitis C treated with simeprevir and sofosbuvir: a case report.
Ende AR; Kim NH; Yeh MM; Harper J; Landis CS
J Med Case Rep; 2015 Jul; 9():164. PubMed ID: 26215390
[TBL] [Abstract][Full Text] [Related]
4. Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge.
De Monte A; Courjon J; Anty R; Cua E; Naqvi A; Mondain V; Cottalorda J; Ollier L; Giordanengo V
J Clin Virol; 2016 May; 78():27-30. PubMed ID: 26967675
[TBL] [Abstract][Full Text] [Related]
5. Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection.
Fontana RJ; Brown RS; Moreno-Zamora A; Prieto M; Joshi S; Londoño MC; Herzer K; Chacko KR; Stauber RE; Knop V; Jafri SM; Castells L; Ferenci P; Torti C; Durand CM; Loiacono L; Lionetti R; Bahirwani R; Weiland O; Mubarak A; ElSharkawy AM; Stadler B; Montalbano M; Berg C; Pellicelli AM; Stenmark S; Vekeman F; Ionescu-Ittu R; Emond B; Reddy KR
Liver Transpl; 2016 Apr; 22(4):446-58. PubMed ID: 26890629
[TBL] [Abstract][Full Text] [Related]
6. No Evidence of Reactivation of Hepatitis B Virus Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection.
Sulkowski MS; Chuang WL; Kao JH; Yang JC; Gao B; Brainard DM; Han KH; Gane E
Clin Infect Dis; 2016 Nov; 63(9):1202-1204. PubMed ID: 27486112
[TBL] [Abstract][Full Text] [Related]
7. Potential risk of HBV reactivation in patients with resolved HBV infection undergoing direct-acting antiviral treatment for HCV.
Ogawa E; Furusyo N; Murata M; Toyoda K; Hayashi T; Ura K
Liver Int; 2018 Jan; 38(1):76-83. PubMed ID: 28618152
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of dolutegravir and rilpivirine in combination with simeprevir and sofosbuvir in HIV/hepatitis C virus-coinfected patients with liver cirrhosis.
Merli M; Galli L; Marinaro L; Ariaudo A; Messina E; Uberti-Foppa C; Castagna A; D'Avolio A; Lazzarin A; Bonora S; Hasson H
J Antimicrob Chemother; 2017 Mar; 72(3):812-815. PubMed ID: 27999010
[TBL] [Abstract][Full Text] [Related]
9. HBV reactivation during direct-acting antiviral therapy in hepatitis B and C coinfected patients undergoing haemodialysis.
Wang J; Hu C; Chen Y; Liu Z; Yu Q; Yang S; Dong J; Yang Y; Wu Y; Ren D; Yao N; Guo D; Tian Z; Zhao Y; Chen T; He Y; Liu J
Antivir Ther; 2019; 24(2):77-84. PubMed ID: 30833515
[TBL] [Abstract][Full Text] [Related]
10. A case of acute hepatitis B in a chronic hepatitis C patient after daclatasvir and asunaprevir combination therapy: hepatitis B virus reactivation or acute self-limited hepatitis?
Hayashi K; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Nishimura D; Goto H; Hirooka Y
Clin J Gastroenterol; 2016 Aug; 9(4):252-6. PubMed ID: 27329484
[TBL] [Abstract][Full Text] [Related]
11. Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antivirals.
Yeh ML; Huang CF; Hsieh MH; Ko YM; Chen KY; Liu TW; Lin YH; Liang PC; Hsieh MY; Lin ZY; Chen SC; Huang CI; Huang JF; Kuo PL; Dai CY; Yu ML; Chuang WL
J Gastroenterol Hepatol; 2017 Oct; 32(10):1754-1762. PubMed ID: 28230928
[TBL] [Abstract][Full Text] [Related]
12. Simeprevir and sofosbuvir for treatment of chronic hepatitis C infection.
Childs-Kean LM; Hand EO
Clin Ther; 2015 Feb; 37(2):243-67. PubMed ID: 25601269
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting System.
Bersoff-Matcha SJ; Cao K; Jason M; Ajao A; Jones SC; Meyer T; Brinker A
Ann Intern Med; 2017 Jun; 166(11):792-798. PubMed ID: 28437794
[TBL] [Abstract][Full Text] [Related]
14. Sofosbuvir and simeprevir combination therapy in the setting of liver transplantation and hemodialysis.
Perumpail RB; Wong RJ; Ha LD; Pham EA; Wang U; Luong H; Kumari R; Daugherty TJ; Higgins JP; Younossi ZM; Kim WR; Glenn JS; Ahmed A
Transpl Infect Dis; 2015 Apr; 17(2):275-8. PubMed ID: 25641426
[TBL] [Abstract][Full Text] [Related]
15. Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks Posttreatment.
Liu CJ; Sheen IS; Chen CY; Chuang WL; Wang HY; Tseng KC; Chang TT; Yang J; Massetto B; Suri V; Camus G; Jiang D; Zhang F; Gaggar A; Hu TH; Hsu YC; Lo GH; Chu CJ; Chen JJ; Peng CY; Chien RN; Chen PJ
Clin Infect Dis; 2022 Aug; 75(3):453-459. PubMed ID: 34864948
[TBL] [Abstract][Full Text] [Related]
16. Severe hepatitis B reactivation during direct-acting antiviral treatment in "the absence" of hepatitis B surface antigen.
Sastre L; Ruiz P; Costa J; Forns X
Int J Infect Dis; 2019 Feb; 79():47-49. PubMed ID: 30496851
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus reactivation sustained by a hepatitis B virus surface antigen immune-escape mutant isolate in a patient who was hepatitis B core antibody positive during treatment with sofosbuvir and velpatasvir for hepatitis C virus infection: a case report.
Foroghi Biland L; Ferrari L; Malagnino V; Teti E; Cerva C; Gentile A; Aragri M; Salpini R; Svicher V; Andreoni M; Sarmati L
J Med Case Rep; 2019 Sep; 13(1):299. PubMed ID: 31542053
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis.
Mücke MM; Backus LI; Mücke VT; Coppola N; Preda CM; Yeh ML; Tang LSY; Belperio PS; Wilson EM; Yu ML; Zeuzem S; Herrmann E; Vermehren J
Lancet Gastroenterol Hepatol; 2018 Mar; 3(3):172-180. PubMed ID: 29371017
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B reactivation in patients with chronic hepatitis C undergoing anti-viral therapy with an interferon-free regimen.
Londoño MC; Lens S; Mariño Z; Bonacci M; Ariza X; Broquetas T; Pla A; Bartres C; Adriani MV; Rodríguez-Tajes S; Costa J; Carrión JA; Pérez-Del-Pulgar S; Forns X
Aliment Pharmacol Ther; 2017 Apr; 45(8):1156-1161. PubMed ID: 28206681
[TBL] [Abstract][Full Text] [Related]
20. Colitis during new direct-acting antiviral agents (DAAs) therapy with sofosbuvir, simeprevir and ribavirin for genotype 1b hepatitis C.
Izzo I; Zanotti P; Chirico C; Casari S; Villanacci V; Salemme M; Biasi L; Festa E; Castelli F
Infection; 2016 Dec; 44(6):811-812. PubMed ID: 27311809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
